Elevated levels of IL‐6 are described in malignancies of the kidney, bladder, colorectal region, ovaries, gallbladder, pancreas, lymphatic tissue, and specifically in squamous cell carcinoma of head and neck (SCCHN) (Lacina et al. 2018). Here, IL6 is linked to head and neck squamous cell carcinoma.